loader

Check LinkedIn Post

Language

EU Importation and MIA Support

EU Importation and MIA

A controlled EU importation route before market access becomes a release risk.

We help MAHs, importers, virtual companies, and manufacturers build a controlled EU importation route through MIA expectations, third-country supply chains, QP certification interfaces, pharmacovigilance links, and AFMPS-ready quality governance before batches are already in motion.

Plan importation support Explore the scope Explore the MIA model
  • MIA framework
  • QP certification
  • Third-country supply
  • Quality agreements
  • Cold-chain routes
  • AFMPS readiness

Importation Route Control

We map responsibilities across MAH, importer, QP, manufacturer, warehouse, transport and third-country partners before batches move.

Risk-Based Readiness

We focus on MIA, GMP, GDP, temperature, documentation and authority expectations that can block EU market access.

Release Evidence

We help compile practical importation evidence so QP certification interfaces are clear, usable and inspection-ready.

EU Importation Support

What we control
before EU importation
becomes a release risk.

MIA Compliance & Importation Framework

  • Assessment of the proposed importation route against MIA, EU GMP, GDP, and national authority expectations.
  • Definition of importer, QP, MAH, manufacturer, warehouse, and transport responsibilities.
  • Practical remediation plan for missing agreements, procedures, or evidence.
Explore the MIA model

Risk Assessment & Gap Analysis

  • Risk assessment of product, route, partners, temperature conditions, and documentation flow.
  • Gap analysis of current systems against EU importation and inspection expectations.
  • Prioritized corrective actions so market access work stays focused.

Regulatory Dossier and Variation Interfaces

  • Support to align dossier status, variations, and renewals with the importation route.
  • Coordination with RA teams to ensure quality and regulatory assumptions match.
  • Follow-up through lifecycle changes that may affect importation or QP certification.

Pharmacovigilance and Regulatory Vigilance Interfaces

  • Coordination with PV and RA interfaces where imported products require safety or quality-defect escalation paths.
  • Regulatory intelligence to anticipate evolving EMA and national authority expectations.
  • Support for recall, defect, and communication pathways that must be clear before launch.

Market Access & Regulatory Strategy

  • Strategy for entering, expanding, or redesigning an EU importation model.
  • Alignment of regulatory pathway, quality documentation, supply-chain reality, and business timing.
  • Support for authority interactions where importation assumptions need to be defended.

Importation Quality Oversight (Non-Release Tasks)

  • Verification that suppliers, transporters, and warehouses are qualified before QP certification is expected.
  • Review of CoA, CoC, temperature data, transport deviations, storage conditions, and supply-chain documentation.
  • Compilation of release-supporting importation evidence without replacing the QP decision.

Supply Chain Verification for Imported Products

  • Oversight of 2-8°C, -20°C, -70°C, and ultra-cold-chain routes where applicable.
  • Review of transport lanes, partner qualification, and deviations linked to import activity.
  • Quality agreements that make responsibilities clear across third-country and EU partners.

Administrative Support for EU Importation

  • Coordination with customs, freight forwarders, and logistics partners when documentation flow affects importation readiness.
  • Completeness review for shipping documents, proforma invoices, import certificates, and quality evidence.
  • Follow-up until the batch is ready for QP review and certification.
01

Controlled EU Import Compliance

A connected importation framework from EU entry to QP certification, with MIA, QTA, eQMS, and AFMPS expectations built into the route.

02

Risk-Based Quality Oversight

Product, partner, route, documentation, cold-chain, recall, return, complaint, and supplier risks are assessed before they become release constraints.

03

Aligned Market Access

Faster alignment with RA, QA, PV, QP, RP, supply chain, and competent-authority expectations.

Experience with recurring importation and certification workflows

Built for manufacturers, MAHs, importers, and virtual companies

Senior QP import expertise across complex routes

Integrated with QA, RA, PV, QP, and supply-chain routines

// EU importation support

From third-country manufacturing to compliant EU market entry.

Support covers market entry, route redesign, MIA compliance, QP interface readiness, eQMS integration, and the day-to-day control of complex imported products.

MAHs, importers, virtual companies, biotech teams, and distribution networks often need more than a release step. They need a coordinated framework covering quality systems, GDP and GMP interfaces, pharmacovigilance, supplier qualification, transport, recalls, and supply-chain execution.

New launches into the European Union

A strong fit when a company is entering the EU for the first time and needs a practical importation route, MIA scope, QTA integration, defined responsibilities, and a clear path to compliant market access.

Recovery of weak importation, MIA, or eQMS frameworks

Useful when the existing setup is fragmented, authority expectations are rising, or quality agreements, eQMS records, route controls, and documentation practices need remediation before they become inspection issues.

Ongoing continuity for high-risk and cold-chain products

Relevant when import activities depend on strict transport conditions, qualified partners, deviation control, PV or quality-defect escalation, and disciplined execution across third-country manufacturers and EU stakeholders.

// MIA model

Use the QP Pro Services MIA instead of building your own import licence from scratch.

QP Pro Services holds a Belgian Manufacturing and Import Authorisation for human medicinal products and investigational medicinal products, issued by FAMHP / AFMPS. This can support fiscal and/or physical importation through Belgium when the quality, product and partner framework is properly defined.

The model is built around the controlled addition of customer products to the MIA scope after the Quality Technical Agreement and QP-to-QP Agreement are in place. It connects QP batch certification, RP/GDP activities where needed, eQMS onboarding, supplier and customer qualification status, authority interfaces and inspection readiness into one practical importation route.

Explore the MIA model

Define your next
compliance step

Share your context and we will schedule a structured consultation to assess priorities, risks, and the right next step.